Artwork

Content provided by Michael Pauley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Pauley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The abortion pill on trial

49:16
 
Share
 

Manage episode 361014420 series 2925086
Content provided by Michael Pauley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Pauley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In the year 2000 the U.S.

Food and Drug Administration (FDA) approved the drug mifepristone (also known

as RU-486 or Mifeprex) as part of a regimen for chemically induced abortions.

But on April 7, 2023—late on Good Friday—a federal judge in Texas issued a

preliminary injunction that suspended the FDA’s approval of mifepristone,

pending a trial on the merits of the case. The preliminary injunction was

partially reversed on appeal, but the judge’s opinion in Alliance for

Hippocratic Medicine v. FDA casts a spotlight on the damage that

mifepristone has caused to women and their preborn children. Host Michael

Pauley is joined by Adam Schwend of Susan B. Anthony Pro-Life America to

discuss the implications of the Alliance for Hippocratic Medicine case,

regarded by many legal experts as the most important abortion-related

litigation since the Dobbs decision.

  continue reading

115 episodes

Artwork
iconShare
 
Manage episode 361014420 series 2925086
Content provided by Michael Pauley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Pauley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In the year 2000 the U.S.

Food and Drug Administration (FDA) approved the drug mifepristone (also known

as RU-486 or Mifeprex) as part of a regimen for chemically induced abortions.

But on April 7, 2023—late on Good Friday—a federal judge in Texas issued a

preliminary injunction that suspended the FDA’s approval of mifepristone,

pending a trial on the merits of the case. The preliminary injunction was

partially reversed on appeal, but the judge’s opinion in Alliance for

Hippocratic Medicine v. FDA casts a spotlight on the damage that

mifepristone has caused to women and their preborn children. Host Michael

Pauley is joined by Adam Schwend of Susan B. Anthony Pro-Life America to

discuss the implications of the Alliance for Hippocratic Medicine case,

regarded by many legal experts as the most important abortion-related

litigation since the Dobbs decision.

  continue reading

115 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide